▲ Wall Street analysts forecast BIIB to rise 9% over the next 12 months.
Avg Price Target
$207.60
+8.6% upside
According to Wall Street analysts, the average 12-month price target for Biogen Inc. (BIIB) is $207.60, implying +8.6% upside from the current price of $191.11.